Skip to content
Human-limitedLong-acting GnRH agonist for hormone therapy

Leuprolide (Lupron)

Long-acting GnRH agonist for hormone suppression.

Overview

Binds to GnRH receptors with high affinity, causing initial gonadotropin release followed by receptor desensitization and downregulation.

Proposed mechanism

Leuprolide is a potent GnRH agonist that initially stimulates then downregulates pituitary GnRH receptors, suppressing LH/FSH and sex hormone production.

What the evidence supports

Human data exists but the trials are small, short-term, or not yet replicated.

Graded Human-limited

Human data that exists but is thin: open-label work, single-arm studies, small cohorts, or observational follow-up without randomisation.

Key citations

Representative primary sources, including results that did not favour the compound.

  1. [1]

    Leuprolide for prostate cancer

    · DOI:10.1056/NEJM199505043321812 · 1995

  2. [2]

    GnRH agonists review

    · DOI:10.1016/j.eururo.2006.02.015 · 2006

  3. [3]

    Leuprolide for prostate cancer (1995)

    · · 0

  4. [4]

    GnRH agonists review (2006)

    · · 0

Citation records in this build are illustrative placeholders for the design.

Reference information for research purposes. Not medical advice, and not a recommendation to use any compound. Many entries describe substances that are not approved for human use.